Biotts Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.38M

  • Investors
  • 13

Biotts General Information

Description

Developer of a transdermal drug delivery technology designed to enable effective needle-free administration of a wide range of therapeutic molecules. The company offers a proprietary semisolid carrier system that transports both lipophilic and hydrophilic molecules, including peptides and proteins, across the skin, enabling pharmaceutical companies and patients to achieve sustained drug release with improved bioavailability and reduced side effects.

Contact Information

Website
www.biotts.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ulica Wrocławska 44c
  • Bielany Wroclawskie, 55-040
  • Poland
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Ulica Wrocławska 44c
  • Bielany Wroclawskie, 55-040
  • Poland

Biotts Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotts Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 03-Nov-2026 $6.38M Completed Clinical Trials - Phase 1
8. Accelerator/Incubator 23-Apr-2026 Completed Clinical Trials - Phase 1
7. Accelerator/Incubator 05-Oct-2021 Completed Startup
6. Early Stage VC 20-May-2020 Completed Startup
5. Grant 06-Mar-2020 Completed Startup
4. Accelerator/Incubator 01-Jan-2020 Completed Startup
3. Early Stage VC 01-Oct-2018 Completed Startup
2. Accelerator/Incubator 28-Sep-2018 Completed Startup
1. Grant 01-Aug-2018 $606K Completed Startup
To view Biotts’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Biotts Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Biotts Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260355288-A1 Compositions comprising insulin agonists, and said compositions for use in the treatment of diabetes or obesity Pending 28-Sep-2023
WO-2025068976-A1 Compositions comprising insulin agonists, and said compositions for use in the treatment of diabetes or obesity Inactive 28-Sep-2023
EP-3996677-A1 A base and a pharmaceutical composition containing it Inactive 09-Jul-2019
EP-3996677-A4 A base and a pharmaceutical composition containing it Inactive 09-Jul-2019
WO-2021006753-A1 A base and a pharmaceutical composition containing it Inactive 09-Jul-2019 A61K31/445
To view Biotts’s complete patent history, request access »

Biotts Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotts Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
European Innovation Council Accelerator/Incubator
Google Accelerator Accelerator/Incubator Minority
Montis Capital (Warsaw) Venture Capital Minority
PFR Ventures Limited Partner Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Biotts FAQs

  • When was Biotts founded?

    Biotts was founded in 2018.

  • Where is Biotts headquartered?

    Biotts is headquartered in Bielany Wroclawskie, Poland.

  • What is the size of Biotts?

    Biotts has 18 total employees.

  • What industry is Biotts in?

    Biotts’s primary industry is Drug Discovery.

  • Is Biotts a private or public company?

    Biotts is a Private company.

  • What is Biotts’s current revenue?

    The current revenue for Biotts is .

  • How much funding has Biotts raised over time?

    Biotts has raised $8.05M.

  • Who are Biotts’s investors?

    , European Innovation Council, Google Accelerator, Montis Capital (Warsaw), and PFR Ventures are 5 of 13 investors who have invested in Biotts.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process